The FDA has approved Caris Life Sciences’ MI Cancer Seek, a pioneering diagnostic test combining Whole Exome and Whole ...

New data from the Phase 2 OVATION 2 study highlights potential improvements in survival outcomes with IMUNON's IMNN-001 for ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially ...

Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale.

Cytokine therapies have the potential to transform cancer treatment by enhancing the body’s immune response to fight cancer ...

The U.S. Food and Drug Administration (FDA) has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing (NGS)-based companion diagnostic, to identify patients eligible for ...

Researchers at Weill Cornell Medicine have made a breakthrough in the fight against hepatocellular carcinoma (HCC), by identifying a biomarker that could predict which patients are more likely to ...

Don't miss this opportunity to hear their insights and get answers to your questions on how AI is shaping the future of healthcare. The general overview of your report, "AI In Pharmaceuticals Promises ...

This website is organized and funded by Health and Pharma and it is not intended for a specific location or country; it represents a fully international brand. Additionally, it contains promotional ...